Onduo

Onduo

Chronic Disease Management & Digital Therapeutics

About Onduo

Onduo is a virtual care company specializing in chronic disease management with a primary focus on diabetes and hypertension. The company delivers personalized digital health solutions that integrate technology platforms, human coaching, and clinical expertise to help patients better manage their conditions. Onduo's approach combines connected devices, mobile applications, and virtual care teams to provide continuous support and monitoring for individuals with chronic conditions. The platform aims to improve health outcomes while reducing healthcare costs through proactive, data-driven interventions. Onduo serves health plans, employers, and health systems seeking to provide comprehensive virtual care solutions for their members and patients with chronic diseases.

Mission & Story

Founding Story

Onduo was created through a collaboration between Verily Life Sciences (an Alphabet company) and Sanofi, combining technology expertise with pharmaceutical and diabetes care knowledge to address chronic disease management.

Clinical Focus

Medical conditions and clinical areas addressed by Onduo.

diabeteshypertensionchronic disease

Who It Serves

PayersHealth SystemsEmployers

Social & Media

Follow on

Company Details

Founded
2016
Headquarters
Cambridge, MA, USA
Employees
51-200

Work here?

Claim this listing to update company information and connect with our audience.

Claim This Listing

Security & Compliance

HIPAA

Official Sources

Last updated Jun 30, 2026

Similar Companies in this Market

View all 46
Abbott Diabetes Care

Abbott Diabetes Care

Abbott Diabetes Care develops FreeStyle Libre, a world-leading continuous glucose monitoring (CGM) portfolio for diabetes management with advanced analytics and innovation.

Amalgam Rx

Amalgam Rx

Amalgam Rx develops AI-powered digital therapeutics and Software as a Medical Device (SaMD) solutions for chronic disease management. The company partners with life sciences companies, health plans, and providers to deliver regulated digital health applications and EHR-integrated clinical decision support tools.

Arkray

Arkray

ARKRAY USA manufactures and distributes blood glucose monitoring systems, clinical diagnostic equipment, and oral wellness products. The company serves consumers with diabetes, healthcare professionals, and clinical laboratories with accurate, affordable diagnostic solutions.

BeatO

BeatO

BeatO is a digital health platform specializing in diabetes management and weight loss solutions. The company offers smart glucose monitoring devices, GLP-1 weight loss programs, and a comprehensive diabetes care program combining connected devices, doctor consultations, and health coaching for over 2 million patients across India.

Brook Health

Brook Health

AI-powered remote patient monitoring and chronic disease management platform for conditions like diabetes, hypertension, and heart disease.

Cadence

Cadence

Cadence delivers AI-powered remote patient care programs for chronic disease management. The company partners with health systems, payers, and medical groups to provide 24/7 monitoring, medication management, and clinical support for patients with hypertension, heart failure, diabetes, and other chronic conditions.

Cala Health

Cala Health

Cala Health develops the Cala kIQ System, an FDA-cleared wearable device that delivers non-invasive neuromodulation therapy for action hand tremor. The device uses transcutaneous afferent patterned stimulation (TAPS) to provide on-demand tremor relief for people with essential tremor and Parkinson's disease.

Calibrate

Calibrate

Calibrate is a metabolic health company that combines clinician-prescribed GLP-1 medications with 1:1 video coaching and science-backed curriculum to help members achieve sustainable weight loss. Members lose an average of 19% of their body weight achieved over three years.

Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.